Phase 1, Open, Dose-escalation Study to Assess the Efficacy and Safety of Fospropofol Disodium Injection in Healthy Volunteers

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-TNRC-11001251

Enrollment

Unknown

Registered

2011-01-03

Start date

2010-03-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Induction of anesthesia

Interventions

Group A:Fospropofol Disodium as a bolus injection

Eligibility

Sex/Gender

All

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. With informed consent signed; 2. Aged between 18 and 45 years; 3. The subjects were to follow a diet with limited amounts of alcohol and caffeine.

Exclusion criteria

Exclusion criteria: 1. Hypersensitivity to any anesthetic; 2. Known or suspected serious disorders and/or significant dysfunction; 3. An abnormal, clinically significant ECG finding; 4. Participation in an investigational drug study within the previous month; 5. Known or suspected pregnancy; 6. Anatomical malformations expected to produce a difficult intubation and known or suspected history or family history of malignant hyperthermia.

Design outcomes

Primary

Measure	Time frame
Modified OAA/S Score;	—

Countries

China

Contacts

Public ContactJin Liu

ray.lee2009@hotmail.com+86 28 85422520

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026